Matthew J. Binnicker, Ph.D.
Director, Clinical Virology
Practice Vice Chair, Department of Laboratory Medicine and Pathology
Professor of Laboratory Medicine and Pathology

Elie F. Berbari, M.D.
Chair, Infectious Diseases
Professor of Medicine, Infectious Diseases

Locations:

• Geffen Auditorium Hall (Live)
• Broadcast to SMH Alfred M-459 and Baldwin 4-316/Baldwin 4-516

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first-come, first-serve basis.

Learning Objectives:

• Demonstrate current recommendations of testing in the inpatient and outpatient setting
• Review proposed changes to COVID-19 testing during the upcoming influenza season
• Describe the differences between molecular tests, rapid antigen tests and serology assays used to diagnose and manage COVID-19
• Summarize the various clinical situations in which available testing methods for COVID-19 should be used and how results should be interpreted
• Discuss the advantages and limitations of rapid antigen tests for COVID-19
• Review several new testing innovations that may improve our ability to diagnose COVID-19

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.